Faeth Therapeutics, Inc. Increase (Decrease) in Other Operating Assets
Faeth Therapeutics, Inc. (FTH) reported Increase (Decrease) in Other Operating Assets of -$138.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-04
- Faeth Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $304.00K, a 948.28% increase year-over-year.
- Faeth Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$442.00K.
- Faeth Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$178.00K.
- Faeth Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $126.00K.
- Faeth Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2025 was -$80.00K.
- Faeth Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$244.00K.
- Faeth Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2023 was -$22.00K.
- Faeth Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2022 was -$5.00K, a 101.53% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$138.00K 10-Q · filed 2026-08-04 | -$316.00K derived: sum of 3 quarters · filed 2026-08-04 | -$190.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$442.00K 10-Q · filed 2026-05-15 | -$620.00K derived: sum of 2 quarters · filed 2026-05-15 | -$494.00K derived: sum of 3 quarters · filed 2026-05-15 | -$465.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$52.00K derived: sum of 2 quarters · filed 2026-03-30 | -$23.00K derived: sum of 3 quarters · filed 2026-08-04 | -$80.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $155.00K derived: sum of 2 quarters · filed 2026-08-04 | $98.00K 10-Q · filed 2025-11-14 | $98.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$28.00K 10-Q · filed 2026-08-04 | -$28.00K derived: sum of 3 quarters · filed 2026-08-04 | -$89.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$57.00K 10-Q · filed 2026-05-15 | -$57.00K derived: sum of 2 quarters · filed 2026-05-15 | -$118.00K derived: sum of 3 quarters · filed 2026-05-15 | -$245.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$61.00K derived: sum of 2 quarters · filed 2026-03-30 | -$188.00K derived: sum of 3 quarters · filed 2026-03-30 | -$244.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$188.00K derived: sum of 2 quarters · filed 2025-11-14 | -$244.00K 10-Q · filed 2025-11-14 | -$237.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$183.00K 10-Q · filed 2025-08-05 | -$176.00K derived: sum of 3 quarters · filed 2025-08-05 | -$134.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$56.00K 10-Q · filed 2025-05-06 | -$49.00K derived: sum of 2 quarters · filed 2025-05-06 | -$7.00K derived: sum of 3 quarters · filed 2025-05-06 | -$86.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $49.00K derived: sum of 2 quarters · filed 2025-03-28 | -$30.00K derived: sum of 3 quarters · filed 2025-03-28 | -$22.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$37.00K derived: sum of 2 quarters · filed 2024-11-14 | -$29.00K 10-Q · filed 2024-11-14 | -$3.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$71.00K 10-Q · filed 2024-08-06 | -$45.00K derived: sum of 3 quarters · filed 2024-08-06 | -$2.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $8.00K 10-Q · filed 2024-05-09 | $34.00K derived: sum of 2 quarters · filed 2024-05-09 | $77.00K derived: sum of 3 quarters · filed 2024-05-09 | $178.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $69.00K derived: sum of 2 quarters · filed 2024-02-29 | $170.00K derived: sum of 3 quarters · filed 2024-02-29 | -$5.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $144.00K derived: sum of 2 quarters · filed 2023-11-07 | -$31.00K 10-Q · filed 2023-11-07 | $54.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$74.00K 10-Q · filed 2023-08-03 | $11.00K derived: sum of 3 quarters · filed 2023-08-03 | $339.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$175.00K 10-Q · filed 2023-05-09 | -$90.00K derived: sum of 2 quarters · filed 2023-05-09 | $238.00K derived: sum of 3 quarters · filed 2023-05-09 | $202.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $413.00K derived: sum of 2 quarters · filed 2023-03-29 | $377.00K derived: sum of 3 quarters · filed 2023-03-29 | $327.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $328.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $292.00K derived: sum of 2 quarters · filed 2022-11-08 | $242.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$86.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$50.00K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |